Integral Diagnostics Limited announced earnings results for the six months ended 31 December 2017. For the six months, the company reported operating revenue up 5.8% to $92.8 million compared to $87.7 million a year ago. Underlying EBITDA up 12.4% to $19.0 million compared to $16.9 million a year ago. Underlying EBIT up 17.6% to $14.0 million compared to $11.9 million a year ago. Underlying NPAT up 22.7% to $9.2 million compared to $7.5 million a year ago. Statutory NPAT down 4.6% to $8.3 million compared to $8.7 million a year ago. Free cash flow up 70.2% to $17.7 million compared to $10.4 million a year ago. Net debt down 16.4% to $42.3 million as at 31 December 2017 compared to $50.6 million a year ago.